Wiener klinische Wochenschrift
-
Wien. Klin. Wochenschr. · Jan 2012
Multicenter Study Clinical TrialUse of OROS® hydromorphone in the treatment of osteoarthritis and osteoporosis: A pooled analysis of three non-interventional studies focusing on different starting doses.
To determine the effect of a lower starting dose of OROS® hydromorphone compared with a higher starting dose. ⋯ A lower starting dose was associated with better tolerability and a lower number of treatment terminations at a comparable level of pain control with high treatment satisfaction.